FDA Clearance Process May Thwart 2010 Monograph Goal – ONP’s Ganley
This article was originally published in The Rose Sheet
Executive Summary
The Office of Nonprescription Products' goal of completing all OTC monographs by 2010 is viable only if FDA can improve its document-clearance process, according to ONP head Charles Ganley, MD
You may also be interested in...
Acting Commissioner Von Eschenbach Made Permanent In Time For New Year
Andrew von Eschenbach can delete "acting" from his office nameplate; the Senate confirmed him as FDA commissioner Dec. 7 by a comfortable 80-11 margin, ending months of "holds" on the vote and opposition to his nomination from both sides of the aisle
Acting Commissioner Von Eschenbach Made Permanent In Time For New Year
Andrew von Eschenbach can delete "acting" from his office nameplate; the Senate confirmed him as FDA commissioner Dec. 7 by a comfortable 80-11 margin, ending months of "holds" on the vote and opposition to his nomination from both sides of the aisle
FDA Clearance Of OTC Final Rules Targeted For 2010 – ONP
The Office of Nonprescription Products is aiming to wrap up pending over-the-counter final monographs by 2010, according to FDA officials